Page last updated: 2024-09-05

erlotinib hydrochloride and Abdominal Aortic Aneurysm

erlotinib hydrochloride has been researched along with Abdominal Aortic Aneurysm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, E; Daugherty, A; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Kobayashi, T; Obama, T; Rizzo, V; Takayanagi, T; Taro, Y; Tsuji, T1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Abdominal Aortic Aneurysm

ArticleYear
Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
    Clinical science (London, England : 1979), 2015, Volume: 128, Issue:9

    Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Cells, Cultured; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum Stress; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Matrix; Humans; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Time Factors

2015